• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    More On ANP.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Antisense Therapeutics Ltd. (ANP.AX)

    -ASX
    0.09 Down 0.00(1.10%) Dec 21
    Add to Portfolio
    Prev Close:0.09
    Open:0.09
    Bid:0.09
    Ask:0.09
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.09 - 0.09
    52wk Range:0.09 - 0.23
    Volume:50,000
    Avg Vol (3m):237,665
    Market Cap:12.97M
    P/E (ttm):N/A
    EPS (ttm):-0.02
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in AUD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):10.71
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (0-00-31) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Antisense Therapeutics Limited develops and commercializes novel antisense therapeutics in Australia. The company’s product pipeline comprises ATL1102, an antisense inhibitor targeting VLA-4 for the treatment of multiple sclerosis and asthma;... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback